Walleye Capital
JAZZ icon

Walleye Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Walleye Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,000
Closed -$189K – 4953
2026
Q1 		$189K Sell
1,000
-200
-17% -$35K ﹤0.01% 3378
2025
Q4 		$204K Buy
1,200
+700
+140% +$107K ﹤0.01% 3537
2025
Q3 		$65.9K Buy
+500
New +$60K ﹤0.01% 3899
2024
Q3 		– Sell
-6,100
Closed -$651K – 5579
2024
Q2 		$651K Buy
6,100
+3,300
+118% +$363K ﹤0.01% 3268
2024
Q1 		$337K Buy
2,800
+1,000
+56% +$122K ﹤0.01% 3549
2023
Q4 		$221K Sell
1,800
-5,800
-76% -$724K ﹤0.01% 3616
2023
Q3 		$984K Buy
7,600
+5,200
+217% +$693K ﹤0.01% 2264
2023
Q2 		$298K Buy
2,400
+1,700
+243% +$229K ﹤0.01% 2813
2023
Q1 		$102K Sell
700
-2,000
-74% -$296K ﹤0.01% 2920
2022
Q4 		$430K Sell
2,700
-4,400
-62% -$645K 0.01% 1550
2022
Q3 		$946K Buy
+7,100
New +$1.08M 0.02% 1022
2020
Q1 		– Sell
-10,600
Closed -$1.58M – 1299
2019
Q4 		$1.58M Sell
10,600
-73,400
-87% -$9.99M 0.1% 272
2019
Q3 		$10.8M Buy
84,000
+62,900
+298% +$8.43M 0.64% 11
2019
Q2 		$3.01M Buy
21,100
+13,200
+167% +$1.77M 0.33% 36
2019
Q1 		$1.13M Buy
+7,900
New +$1.03M 0.19% 131

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Walleye Capital's JAZZ Position: Q2 2026 in Review

Walleye Capital sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 87,365 shares — an estimated $16.5M sold.

Walleye Capital first reported a position in JAZZ in Q1 2019 and held it in 15 quarters. The position peaked at $19.7M in Q4 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Walleye Capital reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 87,365 Jazz Pharmaceuticals shares in Q2 2026, an estimated $16.5M.
  • Walleye Capital first reported a position in Jazz Pharmaceuticals in Q1 2019 and held it in 15 quarters.
  • Walleye Capital's Jazz Pharmaceuticals position peaked at $19.7M in Q4 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.